Pharmafile - Medical Communications News
Research has indicated that there is no causal link between the use of erectile dysfunction drug Viagra and the development of melanoma, a severe...
Coherus has won a victory against the patents protecting the release of a biosimilar version of AbbVie's Humira.
J&J's diabetes meds pose amputation risk, Chinese death penalty threats over counterfeiting and the UK's talent loss post-Brexit - check out the...
Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but faces a legal...
As the demands of healthcare across the world begin to rise, PwC outlines four strategies for creating value in life sciences.
New research emerging regarding the opioid crisis has shifted to the point of dispensation, to see what can be learnt from observing prescription...
We've collated the most popular pieces on Pharmafile this week so you can digest the biggest news of the week in one place.
In a drastic move to help solve its notorious problem with fraudulent clinical trial data, China has introduced a policy shift in its criminal code...
Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop in the number of reported cases...
Pakistan’s Ministry of National Health Services, Regulations and Coordination has signed an agreement with Novartis to improve access to medicines...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
